Pure Global

Improving Pulmonary Hypertension Screening by Echocardiography - Trial NCT06038149

Access comprehensive clinical trial information for NCT06038149 through Pure Global AI's free database. This phase not specified trial is sponsored by Royal United Hospitals Bath NHS Foundation Trust and is currently Not yet recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06038149
Not yet recruiting
diagnostic test
Trial Details
ClinicalTrials.gov โ€ข NCT06038149
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Improving Pulmonary Hypertension Screening by Echocardiography

Study Focus

Pulmonary Hypertension

Transthoracic echocardiogram

Observational

diagnostic test

Sponsor & Location

Royal United Hospitals Bath NHS Foundation Trust

Bath,Glasgow,Sheffield,Cambridge,London, United Kingdom

Timeline & Enrollment

N/A

Oct 19, 2023

Feb 01, 2025

200 participants

Primary Outcome

Analysis of the IMPULSE algorithm in the assessment of pulmonary hypertension,Analysis of the IMPULSE algorithm in comparison to existing guidlines

Summary

This study aims to assess the application of the novel IMPULSE algorithm for the detection of
 pulmonary hypertension (PH) in those with a low or intermediate probability of PH according
 to the British Society of Echocardiography (ESC) and European Society of Cardiology (ESC)
 guidelines.

ICD-10 Classifications

Primary pulmonary hypertension
Other secondary pulmonary hypertension
Pulmonary heart disease and diseases of pulmonary circulation
Pulmonary heart disease, unspecified
Pulmonary valve disorders

Data Source

ClinicalTrials.gov

NCT06038149

Non-Device Trial